These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 21982243

  • 1. [Oesophageal and gastric pathology: early neoplastic lesions. case 2 and case 3. Dysplasia and superficial cancer on Barrett's oesophagus].
    Fléjou JF.
    Ann Pathol; 2011 Oct; 31(5):363-8. PubMed ID: 21982243
    [No Abstract] [Full Text] [Related]

  • 2. Esophageal polypoid dysplasia of gastric foveolar phenotype with focal intramucosal carcinoma associated with Barrett's esophagus.
    Asthana N, Mandich D, Ligato S.
    Am J Surg Pathol; 2008 Oct; 32(10):1581-5. PubMed ID: 18724240
    [Abstract] [Full Text] [Related]

  • 3. Detection of the risk of adenocarcinoma in Barrett's esophagus by means of tumor markers (p53 and Ki67).
    Trakál E, Guidi A, Butti AL, Trakál JJ, Sambuelli R, Zárate FE.
    Acta Gastroenterol Latinoam; 2010 Sep; 40(3):211-5. PubMed ID: 21049770
    [Abstract] [Full Text] [Related]

  • 4. Barrett's oesophagus: the new endoscopic modalities have a future.
    Deviere J.
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i33-7. PubMed ID: 15711006
    [Abstract] [Full Text] [Related]

  • 5. [Oesophageal and gastric pathology: early neoplastic lesions. case 1: squamous intraepithelial neoplasia of the oesophagus].
    Chatelain D, Fléjou JF.
    Ann Pathol; 2011 Oct; 31(5):356-62. PubMed ID: 21982242
    [No Abstract] [Full Text] [Related]

  • 6. Apoptosis and cell proliferation in the metaplasia-dysplasia-carcinoma-sequence of Barrett's esophagus.
    Halm U, Tannapfel A, Breitung B, Breidert M, Wittekind CW, Mössner J.
    Hepatogastroenterology; 2000 Oct; 47(34):962-6. PubMed ID: 11020858
    [Abstract] [Full Text] [Related]

  • 7. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
    Switzer-Taylor V, Schlup M, Lübcke R, Livingstone V, Schultz M.
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
    [Abstract] [Full Text] [Related]

  • 8. Targeting surveillance in Barrett's esophagus.
    Hillman L.
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1311-2. PubMed ID: 18853989
    [No Abstract] [Full Text] [Related]

  • 9. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
    Sikkema M, Kerkhof M, Steyerberg EW, Kusters JG, van Strien PM, Looman CW, van Dekken H, Siersema PD, Kuipers EJ.
    Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
    [Abstract] [Full Text] [Related]

  • 10. High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins.
    Chatelain D, Fléjou JF.
    Virchows Arch; 2003 Jan; 442(1):18-24. PubMed ID: 12536310
    [Abstract] [Full Text] [Related]

  • 11. Total endoscopic eradication of Barrett's esophagus: study methodology, candidate selection, and clinical outcomes.
    Shaheen NJ, Spechler SJ.
    Endoscopy; 2008 Dec; 40(12):994-9. PubMed ID: 19065482
    [No Abstract] [Full Text] [Related]

  • 12. Barrett's oesophagus: from metaplasia to dysplasia and cancer.
    Fléjou JF.
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i6-12. PubMed ID: 15711008
    [Abstract] [Full Text] [Related]

  • 13. [« Non-intestinal » oesophageal and gastric dysplasia: terminology, diagnostic criteria].
    Chatelain D.
    Ann Pathol; 2012 Nov; 32(5 Suppl):S53-7. PubMed ID: 23127941
    [No Abstract] [Full Text] [Related]

  • 14. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J, Konda VJ, Ross AS, de Tejada AH, Noffsinger A, Hart J, Lin S, Ferguson MK, Posner MC, Waxman I.
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [Abstract] [Full Text] [Related]

  • 15. Lymphatic vessel density in the neoplastic progression of Barrett's oesophagus to adenocarcinoma.
    Brundler MA, Harrison JA, de Saussure B, de Perrot M, Pepper MS.
    J Clin Pathol; 2006 Feb; 59(2):191-5. PubMed ID: 16443737
    [Abstract] [Full Text] [Related]

  • 16. Adenocarcinoma arising in Barrett's esophagus after total gastrectomy.
    Tada T, Suzuki T, Iwafuchi M, Watanabe H, Katayanagi N, Aizawa K, Nishimaki T, Tanaka O, Muto T.
    Am J Gastroenterol; 1990 Nov; 85(11):1503-6. PubMed ID: 2239878
    [Abstract] [Full Text] [Related]

  • 17. Cancer risk in Barrett's oesophagus.
    Dias Pereira A, Suspiro A, Chaves P.
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):915-8. PubMed ID: 18049157
    [Abstract] [Full Text] [Related]

  • 18. Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett's oesophagus.
    Krishnadath KK, Tilanus HW, van Blankenstein M, Bosman FT, Mulder AH.
    J Pathol; 1995 Feb; 175(2):175-80. PubMed ID: 7738712
    [Abstract] [Full Text] [Related]

  • 19. p53 expression in Barrett's oesophagus, dysplasia, and adenocarcinoma using antibody DO-7.
    Symmans PJ, Linehan JM, Brito MJ, Filipe MI.
    J Pathol; 1994 Jul; 173(3):221-6. PubMed ID: 7931842
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic significance of nuclear p53 expression in the surveillance of Barrett's esophagus--a longitudinal study.
    Klump B, Hsieh CJ, Holzmann K, Borchard F, Gaco V, Greschniok A, Eckardt VF, Bettendorf U, Gregor M, Porschen R.
    Z Gastroenterol; 1999 Oct; 37(10):1005-11. PubMed ID: 10549095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.